Antiproteinuric Effect of Losartan in Non-Diabetic Renal Disease Is Not Dependent on ACE Insertion/Deletion Polymorphism

Publisher： Karger

E-ISSN： 1423-0143|29|4|216-224

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.29, Iss.4, 2006-11, pp. : 216-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Combination Treatment with Losartan and Trandolapril on Office and Ambulatory Blood Pressures in Non-Diabetic Renal Disease: A COOPERATE-ABP Substudy

By  

American Journal of Nephrology, Vol. 24, Iss. 5, 2004-12 ,pp. : 543-548

Karger

Access to resources Recommend Favorite

To Treat or Not to Treat? Cost-Effectiveness of Ace Inhibitors in Non-Diabetic Advanced Renal Disease - a Dutch Perspective

By  

Kidney and Blood Pressure Research, Vol. 37, Iss. 2-3, 2013-05 ,pp. : 168-180

Karger

Access to resources Recommend Favorite

ACE Gene Insertion/Deletion Alleles: Transmission from Parents to Dialysis and Nondialysis Patients with Chronic Renal Failure

By  

Nephron, Vol. 88, Iss. 2, 2001-05 ,pp. : 187-188

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Gene Polymorphism Determines the Antiproteinuric and Systemic Hemodynamic Effect of Enalapril in Patients with Proteinuric Renal Disease

By  

Kidney and Blood Pressure Research, Vol. 21, Iss. 1, 1998-06 ,pp. : 66-69

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Diabetic Albuminuria in Patients with NIDDM Followed Up for 9 Years

By  

Nephron, Vol. 80, Iss. 1, 1998-09 ,pp. : 17-24

Karger

Access to resources Recommend Favorite